U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06961474) titled 'Effectiveness of Treatments for Cirrhosis With Varicose Veins' on April 29.
Brief Summary: Liver cirrhosis is the fifth leading cause of death among adults, characterized by diffuse fibrous tissue proliferation and the formation of regenerative nodules and false lobules on the basis of widespread hepatocyte necrosis, leading to severe complications such as portal hypertension and liver failure. Cirrhosis is categorized into compensated and decompensated stages based on the presence or absence of clinical events such as ascites, variceal rupture bleeding, and hepatic encephalopathy. Patients with decompensated cirrhosis have a signific...